Procaps Group Investor Relations Material
Latest events
Investor Update
Procaps Group
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Procaps Group S.A.
Access all reports
Procaps Group S.A. is a healthcare and pharmaceutical company that develops, manufactures, and markets a wide range of pharmaceutical solutions globally. The company's product offerings include branded prescription drugs across various therapeutic areas, over-the-counter (OTC) consumer healthcare products, and high-potency clinical compounds. Additionally, Procaps provides contract drug development and manufacturing services, specializing in soft gelatin capsule technologies. The company's operations are organized into several units, such as Diabetrics, which focuses on diabetes solutions, Farma Procaps, Softi Gel, Vital Care, and Clinical Specialties, each catering to specific healthcare needs. The company is headquartered in Luxembourg, and its shares are listed on the NASDAQ.
Latest articles
)
Lowe's Companies: Building a One-Stop Shop for Home Improvement
Lowe's Companies began as a single store in 1921 and has steadily expanded its footprint and offerings, now operating 1,750 stores across the U.S.
7 May 2025
)
Greg Abel: Succeeding Warren Buffett at Berkshire Hathaway
After decades working with Warren Buffett and Charlie Munger, Greg Abel was named Buffett’s successor as he steps down in late 2025.
5 May 2025
)
Intuitive Surgical: Enhancing Surgery with Robotic Precision
Intuitive Surgical has revolutionized surgery with robotics, building its dominant position through decades of innovation, validation, and expansion.
2 May 2025
Ticker symbol
PROC
Country
🇺🇸 United States